Changing TACTICS in intermediate HCC: TACE plus sorafenib.
Options
BORIS DOI
Publisher DOI
PubMed ID
32169908
Date of Publication
2020-08
Publication Type
article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
cancer liver
Language(s)
en
Additional Credits
Universitätsklinik für Viszerale Chirurgie und Medizin
Department for BioMedical Research, Hepatologie Forschung
Series
Gut
Publisher
BMJ Publishing Group
ISSN
0017-5749
Access(Rights)
open.access